Trust Co. of Vermont bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 20,696 shares of the conglomerate’s stock, valued at approximately $3,942,000.
Other institutional investors also recently bought and sold shares of the company. Principle Wealth Partners LLC acquired a new position in Danaher in the 2nd quarter valued at about $565,000. Requisite Capital Management LLC acquired a new stake in shares of Danaher during the second quarter worth about $627,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Danaher during the second quarter worth about $264,011,000. OneDigital Investment Advisors LLC purchased a new position in shares of Danaher in the second quarter valued at approximately $874,000. Finally, Hikari Power Ltd acquired a new position in shares of Danaher in the second quarter valued at approximately $3,905,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Trading Down 0.0%
NYSE:DHR opened at $202.44 on Tuesday. The stock has a 50-day simple moving average of $193.52 and a 200-day simple moving average of $192.67. The stock has a market cap of $142.31 billion, a P/E ratio of 35.96, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.
Wall Street Analysts Forecast Growth
DHR has been the topic of several recent research reports. Evercore reaffirmed an “outperform” rating and set a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Royal Bank Of Canada boosted their price target on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 22nd. TD Cowen reduced their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Finally, JPMorgan Chase & Co. reduced their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
